Tower Research Capital (TRC)’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271 | Sell |
131
-340
| -72% | -$703 | ﹤0.01% | 5074 |
|
|
2025
Q1 | $791 | Buy |
471
+290
| +160% | +$487 | ﹤0.01% | 4830 |
|
|
2024
Q4 | $398 | Sell |
181
-2,929
| -94% | -$6.44K | ﹤0.01% | 5287 |
|
|
2024
Q3 | $4.63K | Sell |
3,110
-876
| -22% | -$1.31K | ﹤0.01% | 4467 |
|
|
2024
Q2 | $7.89K | Sell |
3,986
-1,710
| -30% | -$3.39K | ﹤0.01% | 4416 |
|
|
2024
Q1 | $17.5K | Buy |
5,696
+5,119
| +887% | +$15.7K | ﹤0.01% | 3119 |
|
|
2023
Q4 | $3.99K | Buy |
+577
| New | +$3.99K | ﹤0.01% | 5011 |
|
|
2023
Q3 | – | Sell |
-120
| Closed | -$323 | – | 6066 |
|
|
2023
Q2 | $323 | Sell |
120
-6,255
| -98% | -$16.8K | ﹤0.01% | 5664 |
|
|
2023
Q1 | $12K | Buy |
6,375
+4,019
| +171% | +$7.57K | ﹤0.01% | 4087 |
|
|
2022
Q4 | $5K | Buy |
2,356
+2,106
| +842% | +$4.47K | ﹤0.01% | 4872 |
|
|
2022
Q3 | $0 | Buy |
+250
| New | – | ﹤0.01% | 6260 |
|